SEK326.20
0.25% yesterday
Stockholm, Sep 27, 05:30 pm CET
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Swedish Orphan Biovitrum Target price 2024 - Analyst rating & recommendation

Swedish Orphan Biovitrum Classifications & Recommendation:

Buy
54%
Hold
38%
Sell
8%

Swedish Orphan Biovitrum Price Target

Target Price SEK321.18
Price SEK326.20
Deviation
Number of Estimates 11
11 Analysts have issued a price target Swedish Orphan Biovitrum 2025 . The average Swedish Orphan Biovitrum target price is SEK321.18. This is lower than the current stock price. The highest price target is
SEK370.00 13.43%
register free of charge
, the lowest is
SEK250.00 23.36%
register free of charge
.
A rating was issued by 13 analysts: 7 Analysts recommend Swedish Orphan Biovitrum to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2025 of . Most analysts recommend the Swedish Orphan Biovitrum stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion SEK 22.12 24.88
17.74% 12.46%
EBITDA Margin 35.37% 36.35%
2.28% 2.77%
Net Margin 11.57% 13.25%
25.54% 14.57%

12 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2024 . The average Swedish Orphan Biovitrum sales estimate is

SEK24.9b
Unlock
. This is
4.93% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK26.0b 9.64%
Unlock
, the lowest is
SEK24.0b 1.27%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 SEK22.1b 17.74%
2024
SEK24.9b 12.46%
Unlock
2025
SEK27.7b 11.33%
Unlock
2026
SEK31.6b 14.22%
Unlock
2027
SEK35.4b 12.00%
Unlock
2028
SEK35.5b 0.13%
Unlock

11 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2024. The average Swedish Orphan Biovitrum EBITDA estimate is

SEK9.0b
Unlock
. This is
12.08% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
SEK9.4b 16.02%
Unlock
, the lowest is
SEK8.4b 3.77%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 SEK7.8b 15.06%
2024
SEK9.0b 15.57%
Unlock
2025
SEK10.8b 19.85%
Unlock
2026
SEK13.1b 21.10%
Unlock
2027
SEK15.3b 16.44%
Unlock
2028
SEK14.5b 5.11%
Unlock

EBITDA Margin

2023 35.37% 2.28%
2024
36.35% 2.77%
Unlock
2025
39.13% 7.65%
Unlock
2026
41.48% 6.01%
Unlock
2027
43.13% 3.98%
Unlock
2028
40.87% 5.24%
Unlock

12 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2024. The average Swedish Orphan Biovitrum net profit estimate is

SEK3.3b
Unlock
. This is
52.07% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK3.7b 69.67%
Unlock
, the lowest is
SEK2.8b 27.96%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 SEK2.6b 12.32%
2024
SEK3.3b 28.86%
Unlock
2025
SEK5.0b 51.83%
Unlock
2026
SEK7.0b 40.14%
Unlock
2027
SEK9.4b 34.11%
Unlock
2028
SEK8.8b 6.40%
Unlock

Net Margin

2023 11.57% 25.54%
2024
13.25% 14.57%
Unlock
2025
18.07% 36.38%
Unlock
2026
22.17% 22.69%
Unlock
2027
26.55% 19.76%
Unlock
2028
24.82% 6.52%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share SEK 7.47 9.63
12.32% 28.92%
P/E 33.89
EV/Sales 5.15

12 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

SEK9.63
Unlock
. This is
52.13% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
SEK10.74 69.67%
Unlock
, the lowest is
SEK8.10 27.96%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 SEK7.47 12.32%
2024
SEK9.63 28.92%
Unlock
2025
SEK14.61 51.71%
Unlock
2026
SEK20.48 40.18%
Unlock
2027
SEK27.47 34.13%
Unlock
2028
SEK25.71 6.41%
Unlock

P/E ratio

Current 51.53 136.38%
2024
33.89 34.23%
Unlock
2025
22.32 34.14%
Unlock
2026
15.93 28.63%
Unlock
2027
11.88 25.42%
Unlock
2028
12.69 6.82%
Unlock

Based on analysts' sales estimates for 2024, the Swedish Orphan Biovitrum stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.40 5.88%
2024
5.15 4.68%
Unlock
2025
4.62 10.18%
Unlock
2026
4.05 12.45%
Unlock
2027
3.61 10.71%
Unlock
2028
3.61 0.13%
Unlock

P/S ratio

Current 4.71 26.23%
2024
4.49 4.70%
Unlock
2025
4.03 10.18%
Unlock
2026
3.53 12.45%
Unlock
2027
3.15 10.71%
Unlock
2028
3.15 0.13%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today